The public cost of 3 statins for primary prevention of cardiovascular events in 7 Middle East countries: not all of them can afford it.
Hussain
H
Isma'eel
Zeina
Z
Mohanna
Ghassan
G
Hamadeh
Elie
E
Alam
Kamal
K
Badr
Samir
S
Alam
Abdallah
A
Rebeiz
D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D003906:Developing Countries / Q000191:economics* / Q000706:statistics & numerical data*; D016527:Drug Costs / Q000706:statistics & numerical data*; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics* / Q000627:therapeutic use; D008877:Middle East / Q000453:epidemiology
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors